TAB2 and lung carcinoma: Our results also demonstrate that ARRB2 can negatively regulate the TRAF6-TAB2 signaling axis for NF-κB activation and the TRAF6-BECN1 signaling axis for autophagy induction, thereby attenuating lung cancer progression induced by TLR3 and TLR4.